Literature DB >> 7694884

Ratios of different serum pancreatic enzymes in the diagnosis and staging of chronic pancreatitis.

J E Domínguez-Muñoz1, O Pieramico, M Büchler, P Malfertheiner.   

Abstract

The aim of this study was to define an optimum serum enzyme ratio for the diagnosis of chronic pancreatitis (CP) and for the evaluation of the stage of the disease. With this goal in mind, a simultaneous and interrelated analysis of different serum pancreatic enzymes was performed in 296 consecutive patients with clinically suspected CP. A total of 167 patients were finally diagnosed with CP and 129 with other digestive diseases (used as controls). Serum values of pancreatic amylase, lipase, immunoreactive trypsin, and their ratios were determined in every patient before final diagnosis was established. Stepwise logistic regression analysis was performed. As expected, abnormally low values of individual serum pancreatic enzymes in the diagnosis of CP were highly specific (92-98%) but very insensitive (20-32%). Their diagnostic usefulness was neither improved by calculation of their ratios nor by the use of multivariate logistic regression analysis. A low pancreatic amylase/lipase ratio correlated with advanced CP (p < 0.01), and had a high degree of accuracy (80.5%) in the evaluation of the stage of the disease (assessed by endoscopic retrograde pancreatography). In conclusion, while serum pancreatic enzymes have limited usefulness in the diagnosis of CP, the pancreatic amylase/lipase ratio could be a simple method for staging the disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694884     DOI: 10.1159/000201042

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  8 in total

1.  Guidelines for the investigation of chronic diarrhoea, 2nd edition.

Authors:  P D Thomas; A Forbes; J Green; P Howdle; R Long; R Playford; M Sheridan; R Stevens; R Valori; J Walters; G M Addison; P Hill; G Brydon
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

2.  Evaluation of Biochemical Markers Serum Amylase and Serum Lipase for the Assessment of Pancreatic Exocrine Function in Diabetes Mellitus.

Authors:  Mahesh Basavaraj Madole; Chandrashekhar M Iyer; Mamatha Thimmanna Madivalar; Satish Kishanrao Wadde; Deepak Sadashiv Howale
Journal:  J Clin Diagn Res       Date:  2016-11-01

3.  Independent association between low serum amylase and non-alcoholic fatty liver disease in asymptomatic adults: a cross-sectional observational study.

Authors:  Kei Nakajima; Haruki Oshida; Toshitaka Muneyuki; Masafumi Saito; Yumiko Hori; Hiroshi Fuchigami; Masafumi Kakei; Hiromi Munakata
Journal:  BMJ Open       Date:  2013-01-03       Impact factor: 2.692

4.  Low serum amylase in association with metabolic syndrome and diabetes: A community-based study.

Authors:  Kei Nakajima; Tohru Nemoto; Toshitaka Muneyuki; Masafumi Kakei; Hiroshi Fuchigami; Hiromi Munakata
Journal:  Cardiovasc Diabetol       Date:  2011-04-17       Impact factor: 9.951

5.  Opposite Expression of SPARC between the Liver and Pancreas in Streptozotocin-Induced Diabetic Rats.

Authors:  Kanikkai Raja Aseer; Sang Woo Kim; Myung-Sook Choi; Jong Won Yun
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

6.  Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study.

Authors:  Wan-Chen Wu; Chih-Yuan Wang
Journal:  Cardiovasc Diabetol       Date:  2013-05-20       Impact factor: 9.951

7.  Latent associations of low serum amylase with decreased plasma insulin levels and insulin resistance in asymptomatic middle-aged adults.

Authors:  Toshitaka Muneyuki; Kei Nakajima; Atsushi Aoki; Masashi Yoshida; Hiroshi Fuchigami; Hiromi Munakata; San-E Ishikawa; Hitoshi Sugawara; Masanobu Kawakami; Shin-Ichi Momomura; Masafumi Kakei
Journal:  Cardiovasc Diabetol       Date:  2012-06-29       Impact factor: 9.951

8.  Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients.

Authors:  Jinmei Yao; Ying Zhao; Juanwen Zhang; Yani Hong; Huanle Lu; Jianping Wu
Journal:  Lipids Health Dis       Date:  2014-12-07       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.